CancerCompass is dedicated to provided you with the most up to date cancer information and news. Visit our website to find all our articles on General Cancer News http://www.cancercompass.com/cancer-news.htm Fri, 20 Nov 2009 00:00:00 GMT Fri, 20 Nov 2009 00:00:00 GMT http://backend.userland.com/rss RSS.NET: http://www.rssdotnet.com/ Roche announced results from the international phase III study PRIMA1, which show that MabThera (rituximab) maintenance therapy can significantly increase the time until the disease progresses in newly-treated patients with advanced follicular lymphoma, a common and slow-developing but incurable form of lymphoma. http://www.cancercompass.com/cancer-news/article/32441.htm CancerCompass Thu, 19 Nov 2009 00:00:00 GMT A long-term study has found that men with low- grade, slow-growing prostate cancer who are managed with active surveillance and no radical treatment have an extremely high survival rate. http://www.cancercompass.com/cancer-news/article/32442.htm CancerCompass Thu, 19 Nov 2009 00:00:00 GMT HistoRx today announced that the Company's proprietary AQUA technology, an automated image analysis platform based on tissue-based quantitative immunofluorescence, was noted in a recent National Comprehensive Cancer Network (NCCN) Task Force Report on hormone receptor testing in breast cancer as one of the promising new strategies being developed for the measurement of ER and PgR in breast cancer tissue. http://www.cancercompass.com/cancer-news/article/32440.htm CancerCompass Thu, 19 Nov 2009 00:00:00 GMT A radiation breakthrough to treat breast cancer patients in one day, as opposed to the current average of six weeks, has arrived at Cancer Treatment Centers of America(R) (CTCA) in Philadelphia. CTCA will become the first in the country to offer this treatment option using the Novac7 technology from Rome, Italy. http://www.cancercompass.com/cancer-news/article/32439.htm CancerCompass Thu, 19 Nov 2009 00:00:00 GMT After four years of research, a new test will help identify cancer in women with ovarian cysts before surgery. Until the OVA1 blood test was created, a precise diagnosis before surgery wasn't possible, said Dr. Frederick R. Ueland, associate professor of gynecologic oncology at the University of Kentucky College of Medicine and a principal investigator on the research project. http://www.cancercompass.com/cancer-news/article/32437.htm CancerCompass Thu, 19 Nov 2009 00:00:00 GMT After losing her mother to cancer, Shelia Weeks, 61, was advised by her doctor to begin receiving mammograms when she was 36. Her mother's cancer was found in her liver, but started in her breast. There was no widespread detection method such as mammograms at that time. She passed away in 1982. http://www.cancercompass.com/cancer-news/article/32438.htm CancerCompass Thu, 19 Nov 2009 00:00:00 GMT Synta Pharmaceuticals Corp, a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated strong activity in multiple tumor models. http://www.cancercompass.com/cancer-news/article/32436.htm CancerCompass Thu, 19 Nov 2009 00:00:00 GMT Joe Bacal survived Hodgkin's lymphoma and now he takes on the Baja 1000 - a 675-mile off-road race through the Mexican desert. Bacal hopes to inspire other cancer patients to take control of their cancer care. http://www.cancercompass.com/cancer-news/article/32435.htm CancerCompass Tue, 17 Nov 2009 00:00:00 GMT According to recent research from the United States, Radiosurgery for brain metastasis fails in some patients, who require further surgical care. In this paper the authors' goal was to evaluate prognostic factors that correlate with the survival of patients who require a resection of a brain metastasis after stereotactic radiosurgery (SRS). http://www.cancercompass.com/cancer-news/article/32433.htm CancerCompass Tue, 17 Nov 2009 00:00:00 GMT The development of stomach cancer is closely associated with chronic inflammation, and the Wnt/beta-catenin signaling pathway is activated in most cases of this cancer. High-mobility group A (HMGA) proteins are oncogenic chromatin factors that are primarily expressed not only in undifferentiated tissues but also in various tumors, scientists writing in the American Journal of Pathology report. http://www.cancercompass.com/cancer-news/article/32432.htm CancerCompass Tue, 17 Nov 2009 00:00:00 GMT Current study results from the report, 'A feasibility study of sequential doublet chemotherapy comprising carboplatin-doxorubicin and carboplatin-paclitaxel for advanced endometrial adenocarcinoma and carcinosarcoma,' have been published. According to a study from the United Kingdom, Platinum compounds, taxanes and anthracyclines provide the major effective drug classes in the treatment of advanced and recurrent endometrial cancer and carcinosarcoma. http://www.cancercompass.com/cancer-news/article/32431.htm CancerCompass Tue, 17 Nov 2009 00:00:00 GMT The American Society of Clinical Oncology (ASCO) has once again recognized Erbitux(R) (cetuximab) as one of the major clinical cancer advances of 2009. This year Erbitux was selected by ASCO for providing the first significant increase in survival for 30 years in the treatment of patients with 1st-line recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN). http://www.cancercompass.com/cancer-news/article/32429.htm CancerCompass Tue, 17 Nov 2009 00:00:00 GMT Oncolytics Biotech Inc. today announced that a poster presentation covering updated results of a Phase I/II U.K. trial (REO 011) of REOLYSIN (R) combined with paclitaxel/carboplatin for patients with advanced cancers will be presented on November 17, 2009 at the 2009 AACR- NCI-EORTC Molecular Targets and Cancer Therapeutics conference being held in Boston, Massachusetts. http://www.cancercompass.com/cancer-news/article/32430.htm CancerCompass Tue, 17 Nov 2009 00:00:00 GMT OSI Pharmaceuticals, Inc. announced today that the Oncologic Drugs Advisory Committee (ODAC) will review the use of Tarceva(R) (erlotinib) as a first-line maintenance therapy for patients with advanced non-small cell lung cancer (NSCLC) who have not progressed following first-line treatment with platinum- based chemotherapy at its December 16, 2009 meeting. http://www.cancercompass.com/cancer-news/article/32428.htm CancerCompass Tue, 17 Nov 2009 00:00:00 GMT Patients with locally advanced esophageal cancer who require neoadjuvant therapy have significant dysphagia. To prospectively evaluate Polyflex stents to treat malignant dysphagia and to ameliorate weight loss in patients with locally advanced esophageal cancer who will undergo neoadjuvant therapy, scientists in the United States report. http://www.cancercompass.com/cancer-news/article/32427.htm CancerCompass Tue, 17 Nov 2009 00:00:00 GMT Accurate assessment of primary tumor size is an essential part of management in breast cancer patients. Tumor size is part of the TNM system used to stage breast cancer and provide prognostic information. Adaptation of the principles of breast conservation surgery requires evaluation of tumor size to judge appropriateness and extent of surgery. Precise measurement of tumor size is also important to monitor response to neoadjuvant chemotherapy for locally advanced tumors. http://www.cancercompass.com/cancer-news/article/32425.htm CancerCompass Tue, 17 Nov 2009 00:00:00 GMT Scientists have long suspected that the soy foods in Asian diets may help explain why people in places like Japan, China, and Singapore have lower rates of breast cancer, prostate cancer, osteoporosis, and heart disease. And thousands of studies over the past two decades- most of them carried out in the West- have tried to figure out whether soybeans are beneficial and, if so, which parts of the soybean are responsible. http://www.cancercompass.com/cancer-news/article/32426.htm CancerCompass Tue, 17 Nov 2009 00:00:00 GMT U.S. health experts say about two-thirds of cancers could be prevented via lifestyle changes. The Mayo Clinic researchers explain in their Special Report on Cancer Prevention in the November issue of Mayo Clinic Women's HealthSource says maintaining proper weight by eating a healthy, low-fat diet and by stepping up moderate to vigorous physical activity to 45 to 60 minutes almost daily might reduce one- third of cancer deaths. http://www.cancercompass.com/cancer-news/article/32421.htm CancerCompass Tue, 17 Nov 2009 00:00:00 GMT When the pain in her knee from an old running injury continued even after surgery, Sarah McCluan turned to the Internet for help. I don't use it to diagnose ,but I do go to the Internet for basic information," said McCluan, who downloaded some knee strengthening exercises that she is following. McCluan, 37, of Hopewell is among a growing number of wired adults searching the Internet for medical information. http://www.cancercompass.com/cancer-news/article/32422.htm CancerCompass Tue, 17 Nov 2009 00:00:00 GMT The number of lymph nodes analyzed in specimens from patients undergoing resection for colon cancer has diagnostic and therapeutic importance. Low lymph node number is a risk factor for poor survival, particularly in patients with Stage II and Stage III disease. http://www.cancercompass.com/cancer-news/article/32420.htm CancerCompass Tue, 17 Nov 2009 00:00:00 GMT